Glycine-induced NMDA receptor internalization provides neuroprotection and preserves vasculature following ischemic stroke

Allen, 1997, The 'sniffer-patch' technique for detection of neurotransmitter release, Trends Neurosci., 20, 192, 10.1016/S0166-2236(96)01039-9 Amiaz, 2015, Safety, tolerability and pharmacokinetics of open label sarcosine added on to anti-psychotic treatment in schizophrenia - preliminary study, Isr. J. Psychiatr. Relat. Sci., 52, 12 Aragon, 1987, Stoichiometry of sodium- and chloride-coupled glycine transport in synaptic plasma membrane vesicles derived from rat brain, FEBS Lett., 212, 87, 10.1016/0014-5793(87)81562-4 Aubrey, 2001, N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport, Br. J. Pharmacol., 134, 1429, 10.1038/sj.bjp.0704381 Aubrey, 2007, The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype, J. Neurosci., 27, 6273, 10.1523/JNEUROSCI.1024-07.2007 Balkaya, 2013, Characterization of long-term functional outcome in a murine model of mild brain ischemia, J. Neurosci. Methods, 213, 179, 10.1016/j.jneumeth.2012.12.021 Balu, 2012, The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex, Neurobiol. Dis., 45, 671, 10.1016/j.nbd.2011.10.006 Basu, 2009, Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior, Mol. Psychiatr., 14, 719, 10.1038/mp.2008.130 Benedek, 2006, Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats, Brain Res., 1116, 159, 10.1016/j.brainres.2006.07.123 Bennett, 2017, Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease, Proc. Natl. Acad. Sci. U S A, 115, E1289 Benneyworth, 2012, Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function, Neuropsychopharmacology, 37, 2496, 10.1038/npp.2012.108 Bergeron, 1998, Modulation of N-methyl-D-aspartate receptor function by glycine transport, Proc. Natl. Acad. Sci. U S A, 95, 15730, 10.1073/pnas.95.26.15730 Biegon, 2018, Stimulation of N-methyl-D-aspartate receptors by exogenous and endogenous ligands improves outcome of brain injury, Curr. Opin. Neurol., 31, 687, 10.1097/WCO.0000000000000612 Biswas, 2020, A large-scale optical microscopy image dataset of potato tuber for deep learning based plant cell assessment, Sci. Data, 7, 371, 10.1038/s41597-020-00706-9 Bouet, 2009, The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice, Nat. Protoc., 4, 1560, 10.1038/nprot.2009.125 Caldinelli, 2009, FAD binding in glycine oxidase from Bacillus subtilis, Biochimie, 91, 1499, 10.1016/j.biochi.2009.09.003 Chen, 2015, Glycine bidirectionally regulates ischemic tolerance via different mechanisms including NR2A-dependent CREB phosphorylation, J. Neurochem., 133, 397, 10.1111/jnc.12994 Chen, 2017, A non-ionotropic activity of NMDA receptors contributes to glycine-induced neuroprotection in cerebral ischemia-reperfusion injury, Sci. Rep., 7, 3575, 10.1038/s41598-017-03909-0 Chen, 2020, Glycine attenuates cerebrovascular remodeling via glycine receptor alpha 2 and vascular endothelial growth factor receptor 2 after stroke, Am. J. Transl. Res., 12, 6895 Choi, 2014, Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons, Mol. Brain, 7, 17, 10.1186/1756-6606-7-17 Cubelos, 2005, Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain, Cereb. Cortex, 15, 448, 10.1093/cercor/bhh147 Deng, 2009, Imagenet: a large-scale hierarchical image database, IEEE Conf. Comput. Vis. Pattern Recogn., 248 Dojo Soeandy, 2019, Endothelin-1-mediated cerebral ischemia in mice: early cellular events and the role of caspase-3, Apoptosis, 24, 578, 10.1007/s10495-019-01541-z Ehara, 2009, Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences, Acta Histochem. Cytochem., 42, 171, 10.1267/ahc.09018 Farr, 2006, Bilateral alteration in stepping pattern after unilateral motor cortex injury: a new test strategy for analysis of skilled limb movements in neurological mouse models, J. Neurosci. Methods, 153, 104, 10.1016/j.jneumeth.2005.10.011 Forsythe, 1988, Modulation of excitatory synaptic transmission by glycine and zinc in cultures of mouse hippocampal neurons, J. Neurosci., 8, 3733, 10.1523/JNEUROSCI.08-10-03733.1988 Furukawa, 2003, Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core, EMBO J., 22, 2873, 10.1093/emboj/cdg303 Gibert-Rahola, 2014, Glutamatergic drugs for schizophrenia treatment, Actas Esp Psiquiatr, 42, 234 Gomeza, 2003, Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition, Neuron, 40, 785, 10.1016/S0896-6273(03)00672-X Gotti, 1988, Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia, J. Pharmacol. Exp. Ther., 247, 1211 Guastella, 1992, Cloning, expression, and localization of a rat brain high-affinity glycine transporter, Proc. Natl. Acad. Sci. U S A, 89, 7189, 10.1073/pnas.89.15.7189 Han, 2013, Identification of a single amino acid in GluN1 that is critical for glycine-primed internalization of NMDA receptors, Mol. Brain, 6, 36, 10.1186/1756-6606-6-36 Harvey, 2013, Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain, Nat. Rev. Drug Discov., 12, 866, 10.1038/nrd3893 Hatfield, 1991, Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion, Neuropathol. Appl. Neurobiol., 17, 61, 10.1111/j.1365-2990.1991.tb00694.x Herdon, 2001, Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes, Neuropharmacology, 41, 88, 10.1016/S0028-3908(01)00043-0 Hu, 2016, Glycine triggers a non-ionotropic activity of GluN2A-containing NMDA receptors to confer neuroprotection, Sci. Rep., 6, 34459, 10.1038/srep34459 Huang, 2016, GlyT1 inhibitor NFPS exerts neuroprotection via GlyR Alpha1 subunit in the rat model of transient focal cerebral ischaemia and reperfusion, Cell Physiol. Biochem., 38, 1952, 10.1159/000445556 Ikonomidou, 2002, Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?, Lancet Neurol., 1, 383, 10.1016/S1474-4422(02)00164-3 Job, 2002, Glycine oxidase from Bacillus subtilis. Characterization of a new flavoprotein, J. Biol. Chem., 277, 6985, 10.1074/jbc.M111095200 Johnson, 1987, Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature, 325, 529, 10.1038/325529a0 Johnson, 1992, Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neurons, J. Physiol., 455, 339, 10.1113/jphysiol.1992.sp019305 Kalia, 2008, NMDA receptors in clinical neurology: excitatory times ahead, Lancet Neurol., 7, 742, 10.1016/S1474-4422(08)70165-0 Kannangara, 2015, GluN2A-/- mice lack bidirectional synaptic plasticity in the dentate gyrus and perform poorly on spatial pattern separation tasks, Cereb. Cortex, 25, 2102, 10.1093/cercor/bhu017 Ke, 2013, SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction, Nat. Neurosci., 16, 1154, 10.1038/nn.3447 Kermany, 2018, Identifying medical diagnoses and treatable diseases by image-based deep learning, Cell, 172, 1122, 10.1016/j.cell.2018.02.010 Kirchhausen, 2008, Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis, Methods Enzymol., 438, 77, 10.1016/S0076-6879(07)38006-3 Kleckner, 1988, Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes, Science, 241, 835, 10.1126/science.2841759 Kostandy, 2012, The role of glutamate in neuronal ischemic injury: the role of spark in fire, Neurol. Sci., 33, 223, 10.1007/s10072-011-0828-5 Lai, 1999, The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis, J. Biol. Chem., 274, 25963, 10.1074/jbc.274.37.25963 Lee, 2007, Astrocytic control of synaptic NMDA receptors, J. Physiol., 581, 1057, 10.1113/jphysiol.2007.130377 Lee, 2007, Photochemically induced cerebral ischemia in a mouse model, Surg. Neurol., 67, 620, 10.1016/j.surneu.2006.08.077 Lin, 2017, Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: a randomised, double-blind, placebo-controlled trial, World J. Biol. Psychiatr., 18, 357, 10.3109/15622975.2015.1117654 Lipton, 2004, Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults, NeuroRx, 1, 101, 10.1602/neurorx.1.1.101 Liu, 2005, Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding, J. Pharmacol. Exp. Ther., 313, 1254, 10.1124/jpet.104.079319 Liu, 2019, Glycine exhibits neuroprotective effects in ischemic stroke in rats through the inhibition of M1 microglial polarization via the NF-kappaB p65/Hif-1alpha signaling pathway, J. Immunol., 202, 1704, 10.4049/jimmunol.1801166 Mallorga, 2003, Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine, Neuropharmacology, 45, 585, 10.1016/S0028-3908(03)00227-2 Mangin, 2003, Kinetic properties of the alpha2 homo-oligomeric glycine receptor impairs a proper synaptic functioning, J. Physiol., 553, 369, 10.1113/jphysiol.2003.052142 Martina, 2004, Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels, J. Physiol., 557, 489, 10.1113/jphysiol.2004.063321 Martina, 2005, Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice, J. Physiol., 563, 777, 10.1113/jphysiol.2004.080655 Matsumoto, 2019, Advanced CUBIC tissue clearing for whole-organ cell profiling, Nat. Protoc., 14, 3506, 10.1038/s41596-019-0240-9 Metz, 2009, The ladder rung walking task: a scoring system and its practical application, J. Vis. Exp., 1204 Molla, 2003, Kinetic mechanisms of glycine oxidase from Bacillus subtilis, Eur. J. Biochem., 270, 1474, 10.1046/j.1432-1033.2003.03513.x Muller, 2013, Vesicular storage of glycine in glutamatergic terminals in mouse hippocampus, Neuroscience, 242, 110, 10.1016/j.neuroscience.2013.03.007 Nong, 2003, Glycine binding primes NMDA receptor internalization, Nature, 422, 302, 10.1038/nature01497 Nong, 2004, NMDA receptors are movin, Curr. Opin. Neurobiol., 14, 353, 10.1016/j.conb.2004.05.001 Paoletti, 1995, Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+, Neuron, 15, 1109, 10.1016/0896-6273(95)90099-3 Papouin, 2012, Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists, Cell, 150, 633, 10.1016/j.cell.2012.06.029 Park, 1989, Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat, J. Cereb. Blood Flow Metab., 9, 617, 10.1038/jcbfm.1989.88 Pedotti, 2009, Catalytic and redox properties of glycine oxidase from Bacillus subtilis, Biochimie, 91, 604, 10.1016/j.biochi.2009.02.007 Pineiro, 2000, Relating MRI changes to motor deficit after ischemic stroke by segmentation of functional motor pathways, Stroke, 31, 672, 10.1161/01.STR.31.3.672 Pinto, 2015, Glycine transporters type 1 inhibitor promotes brain preconditioning against NMDA-induced excitotoxicity, Neuropharmacology, 89, 274, 10.1016/j.neuropharm.2014.10.003 Prass, 1998, Glutamate antagonists in therapy of stroke, Restor. Neurol. Neurosci., 13, 3 Qin, 2019, MicroRNA-26b/PTEN signaling pathway mediates glycine-induced neuroprotection in SAH injury, Neurochem. Res., 44, 2658, 10.1007/s11064-019-02886-2 Rosenmund, 1998, The tetrameric structure of a glutamate receptor channel, Science, 280, 1596, 10.1126/science.280.5369.1596 Rossi, 2000, Glutamate release in severe brain ischaemia is mainly by reversed uptake, Nature, 403, 316, 10.1038/35002090 Rossi, 2007, Astrocyte metabolism and signaling during brain ischemia, Nat. Neurosci., 10, 1377, 10.1038/nn2004 Sakimura, 1995, Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit, Nature, 373, 151, 10.1038/373151a0 Scain, 2010, Glycine release from radial cells modulates the spontaneous activity and its propagation during early spinal cord development, J. Neurosci., 30, 390, 10.1523/JNEUROSCI.2115-09.2010 Scatton, 1994, Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases, Life Sci., 55, 2115, 10.1016/0024-3205(94)00392-0 Schallert, 2000, CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury, Neuropharmacology, 39, 777, 10.1016/S0028-3908(00)00005-8 Settembre, 2003, Structural and mechanistic studies on ThiO, a glycine oxidase essential for thiamin biosynthesis in Bacillus subtilis, Biochemistry, 42, 2971, 10.1021/bi026916v Shahsavar, 2021, Structural insights into the inhibition of glycine reuptake, Nature, 591, 677, 10.1038/s41586-021-03274-z Smith, 1992, Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors, Neuron, 8, 927, 10.1016/0896-6273(92)90207-T Sommer, 2017, Ischemic stroke: experimental models and reality, Acta Neuropathol., 133, 245, 10.1007/s00401-017-1667-0 Stanton, 2009, Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13, Neuroreport, 20, 1193, 10.1097/WNR.0b013e32832f5130 Strzelecki, 2014, Two grams of sarcosine in schizophrenia - is it too much? A potential role of glutamate-serotonin interaction, Neuropsychiatr. Dis. Treat., 10, 263, 10.2147/NDT.S54024 Strzelecki, 2015, No changes of cardiometabolic and body composition parameters after 6-month add-on treatment with sarcosine in patients with schizophrenia, Psychiatr. Res., 230, 200, 10.1016/j.psychres.2015.08.040 Toussay, 2019, Laser doppler flowmetry to study the regulation of cerebral blood flow by G protein-coupled receptors in rodents, Methods Mol. Biol., 1947, 377, 10.1007/978-1-4939-9121-1_22 Traynelis, 2010, Glutamate receptor ion channels: structure, regulation, and function, Pharmacol. Rev., 62, 405, 10.1124/pr.109.002451 Tsai, 2004, Gene knockout of glycine transporter 1: characterization of the behavioral phenotype, Proc. Natl. Acad. Sci. U S A, 101, 8485, 10.1073/pnas.0402662101 Tsai, 2009, Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels, J. Neurosci., 29, 14553, 10.1523/JNEUROSCI.3287-09.2009 Wang, 2007, Neurogenesis associated with endothelin-induced cortical infarction in the mouse, Brain Res., 1167, 118, 10.1016/j.brainres.2007.06.065 Wolosker, 1999, Purification of serine racemase: biosynthesis of the neuromodulator D-serine, Proc. Natl. Acad. Sci. U S A, 96, 721, 10.1073/pnas.96.2.721 Wu, 2018, Targeting NMDA receptors in stroke: new hope in neuroprotection, Mol. Brain, 11, 15, 10.1186/s13041-018-0357-8 Yamamoto, 2016, Identification of 1-methyl-N-(propan-2-yl)-N-({2-[4-(trifluoromethoxy)phenyl]pyridin-4-yl}methyl)-1 H-imidazole-4-carboxamide as a potent and orally available Glycine transporter 1 inhibitor, Chem. Pharm. Bull. (Tokyo), 64, 1630, 10.1248/cpb.c16-00610 Yao, 2012, Glycine exerts dual roles in ischemic injury through distinct mechanisms, Stroke, 43, 2212, 10.1161/STROKEAHA.111.645994 Yu, 2018, Bisenet: bilateral segmentation network for real-time semantic segmentation, Proc. Eur. Conf. Comput. Vis. (Eccv), 325 Zhao, 2018, Glycine confers neuroprotection through PTEN/AKT signal pathway in experimental intracerebral hemorrhage, Biochem. Biophys. Res. Commun., 501, 85, 10.1016/j.bbrc.2018.04.171 Zheng, 2017, GLYX-13, a NMDA receptor glycine-site functional partial agonist, attenuates cerebral ischemia injury in vivo and vitro by differential modulations of NMDA receptors subunit components at different post-ischemia stage in mice, Front. Aging Neurosci., 9, 186, 10.3389/fnagi.2017.00186